| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |